Skip to main content

Oak Street Health, Inc.

OSHDelisted May 2, 2023
Industry
Services-Health Services
SEC CIK
0001564406

Oak Street Health, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on May 4, 2023; 273 institutions reported holding it in 13F filings for Q1 2023, worth $8.37B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Oak Street Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Oak Street Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Oak Street Health, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wassong David10% Owner0IndirectMay 4, 20230
Yadav Ravi10% Owner0IndirectMay 4, 20230
Newlight Partners LPDirector, 10% Owner0IndirectMay 4, 20230
Newlight GP LLC10% Owner0IndirectMay 4, 20230
Newlight Harbour Point SPV LLC10% Owner0IndirectMay 4, 20230
General Atlantic, L.P.Director, 10% Owner0IndirectMay 2, 20230
Gap Coinvestments III, LLC10% Owner0IndirectMay 2, 20230
Gap Coinvestments IV, LLC10% Owner0IndirectMay 2, 20230
GAP Coinvestments CDA, L.P.10% Owner0IndirectMay 2, 20230
General Atlantic Genpar, L.P.10% Owner0IndirectMay 2, 20230
General Atlantic Partners 93, L.P.10% Owner0IndirectMay 2, 20230
General Atlantic Partners 100, L.P.10% Owner0IndirectMay 2, 20230
General Atlantic (OSH) Interholdco, L.P.10% Owner0IndirectMay 2, 20230
General Atlantic (SPV) GP, LLC10% Owner0IndirectMay 2, 20230
GAP Coinvestments V, LLC10% Owner0IndirectMay 2, 20230
Kusserow Paul B. K.Director0May 2, 20230
Dorsey CherylDirector0May 2, 20230
Klapstein Julie DDirector0May 2, 20230
Benjamin Regina M.Director0May 2, 20230
Kaushal MohitDirector0May 2, 20230
Pykosz Michael TChief Executive Officer0IndirectMay 2, 20230
Price Geoffrey MChief Innovation Officer0IndirectMay 2, 20230
Guenthner RobertChief Legal Officer0May 2, 20230
Myers GriffinChief Medical Officer0IndirectMay 2, 20230
Cook Timothy MChief Financial Officer0IndirectMay 2, 20230
Keck KimDirector0May 2, 20230
Clem BrianChief Operating Officer0May 2, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 2, 2022 (view filing)May 312 daysPrice Geoffrey MChief Innovation OfficerSSaleCommon Stock, $0.001 par value−120.0K$18.91−$2.27M−6.0%1.89M after
May 4, 2022 (view filing)May 31 dayPrice Geoffrey MChief Innovation OfficerSSaleCommon Stock, $0.001 par value−60.0K$18.91−$1.13M−2.9%2.01M after2 lots
Apr 20, 2022 (view filing)Apr 191 dayPrice Geoffrey MChief Innovation OfficerSSaleCommon Stock, $0.001 par value−60.0K$24.91−$1.49M−2.8%2.07M after2 lots
Apr 6, 2022 (view filing)Apr 51 dayPrice Geoffrey MChief Innovation OfficerSSaleCommon Stock, $0.001 par value−60.0K$26.56−$1.59M−2.7%2.13M after2 lots
Mar 24, 2022 (view filing)Mar 222 daysPrice Geoffrey MChief Innovation OfficerSSaleCommon Stock, $0.001 par value−80.0K$24.83−$1.99M−3.5%2.20M after3 lots
Mar 7, 2022 (view filing)Mar 34 daysClem BrianChief Operating OfficerSSaleCommon Stock, $0.001 par value−15.0K$21.35−$320.3K−2.3%636.5K after2 lots
Feb 18, 2022 (view filing)Feb 171 dayClem BrianChief Operating OfficerSSaleCommon Stock, $0.001 par value−15.0K$16.45−$246.7K−2.5%581.6K after2 lots
Feb 7, 2022 (view filing)Feb 43 daysGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−606$16.66−$10.1K−0.1%443.8K after
Feb 7, 2022 (view filing)Feb 43 daysCook Timothy MChief Financial OfficerSSaleCommon Stock, $0.001 par value−1.51K$16.66−$25.2K−0.1%1.29M after
Feb 7, 2022 (view filing)Feb 43 daysClem BrianChief Operating OfficerSSaleCommon Stock, $0.001 par value−1.15K$16.66−$19.2K−0.2%596.6K after
Jan 13, 2022 (view filing)Jan 112 daysPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−12.5K$25.02−$312.8K−0.5%2.28M after
Jan 5, 2022 (view filing)Jan 41 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−25.0K$33.19−$829.8K−0.3%7.35M afterFrom original3 lots
Dec 28, 2021 (view filing)Dec 28Same dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−27.5K$34.10−$937.7K−1.2%2.29M after2 lots
Dec 17, 2021 (view filing)Dec 161 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−2.53K$31.46−$79.7K−0.6%444.4K after2 lots
Dec 16, 2021 (view filing)Dec 142 daysPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−27.5K$32.02−$880.5K−1.2%2.32M after2 lots
Dec 3, 2021 (view filing)Dec 21 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−419$31.44−$13.2K−0.1%456.9K after
Nov 24, 2021 (view filing)Nov 231 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−27.5K$31.82−$875.1K−1.2%2.35M after4 lots
Nov 19, 2021 (view filing)Nov 181 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−1.48K$36.76−$54.3K−0.3%457.3K after2 lots
Nov 18, 2021 (view filing)Nov 162 daysMyers GriffinChief Medical OfficerSSaleCommon Stock, $0.001 par value−86.0K$40.30−$3.47M−1.6%5.24M after
Nov 18, 2021 (view filing)Nov 162 daysPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$39.76−$1.99M−0.7%7.37M after2 lots
Nov 16, 2021 (view filing)Nov 151 dayMyers GriffinChief Medical OfficerSSaleCommon Stock, $0.001 par value−23.4K$40.00−$935.3K−0.4%5.32M after
Nov 10, 2021 (view filing)Nov 91 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−28.1K$37.78−$1.06M−1.2%2.38M after6 lots
Nov 5, 2021 (view filing)Nov 41 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−5.90K$46.09−$272.0K−1.3%458.8K after3 lots
Nov 3, 2021 (view filing)Nov 21 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$45.62−$2.28M−0.7%7.42M after4 lots
Oct 29, 2021 (view filing)Oct 281 dayCook Timothy MChief Financial OfficerSSaleCommon Stock, $0.001 par value−15.0K$46.65−$699.7K−1.1%1.29M after2 lots
Oct 26, 2021 (view filing)Oct 26Same dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−72.5K$45.24−$3.28M−2.9%2.40M after2 lots
Oct 22, 2021 (view filing)Oct 211 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−10.3K$45.75−$472.5K−2.2%466.3K after4 lots
Oct 21, 2021 (view filing)Oct 192 daysPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$41.82−$2.09M−0.7%7.47M after2 lots
Oct 18, 2021 (view filing)Oct 153 daysMyers GriffinChief Medical OfficerSSaleCommon Stock, $0.001 par value−109.4K$41.65−$4.56M−2.0%5.35M after2 lots
Oct 14, 2021 (view filing)Oct 122 daysPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−27.5K$37.24−$1.02M−1.1%2.48M after3 lots
Oct 8, 2021 (view filing)Oct 71 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−1.48K$41.48−$61.2K−0.3%475.1K after2 lots
Oct 6, 2021 (view filing)Oct 51 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$41.75−$2.09M−0.7%7.52M after2 lots
Sep 29, 2021 (view filing)Sep 281 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−50.0K$46.13−$2.31M−2.0%2.50M after
Sep 24, 2021 (view filing)Sep 231 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−5.90K$49.82−$294.1K−1.2%476.5K after6 lots
Sep 22, 2021 (view filing)Sep 211 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$50.38−$2.52M−0.7%7.57M after2 lots
Sep 20, 2021 (view filing)Sep 164 daysCook Timothy MChief Financial OfficerSSaleCommon Stock, $0.001 par value−15.0K$52.04−$780.6K−1.1%1.31M after2 lots
Sep 16, 2021 (view filing)Sep 151 dayMyers GriffinChief Medical OfficerSSaleCommon Stock, $0.001 par value−109.4K$52.00−$5.69M−2.0%5.46M after2 lots
Sep 15, 2021 (view filing)Sep 141 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−50.0K$52.41−$2.62M−1.9%2.55M after3 lots
Sep 13, 2021 (view filing)Sep 94 daysGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−5.90K$52.16−$307.8K−1.2%482.4K after3 lots
Sep 8, 2021 (view filing)Sep 71 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$51.73−$2.59M−0.7%7.62M after3 lots
Sep 7, 2021 (view filing)Sep 25 daysCook Timothy MChief Financial OfficerSSaleCommon Stock, $0.001 par value−5.43K$48.88−$265.6K−0.4%1.32M after
Sep 1, 2021 (view filing)Aug 311 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$46.19−$2.31M−0.6%7.67M after2 lots
Aug 27, 2021 (view filing)Aug 261 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−5.90K$47.12−$278.1K−1.2%488.3K after4 lots
Aug 25, 2021 (view filing)Aug 241 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−50.0K$47.61−$2.38M−1.9%2.60M after
Aug 20, 2021 (view filing)Aug 191 dayCook Timothy MChief Financial OfficerSSaleCommon Stock, $0.001 par value−9.57K$45.40−$434.3K−0.7%1.33M after2 lots
Aug 18, 2021 (view filing)Aug 171 dayPykosz Michael TChief Executive OfficerSSaleCommon Stock, $0.001 par value−50.0K$46.69−$2.33M−0.6%7.72M after2 lots
Aug 17, 2021 (view filing)Aug 161 dayMyers GriffinChief Medical OfficerSSaleCommon Stock, $0.001 par value−109.4K$48.46−$5.30M−1.9%5.57M after4 lots
Aug 13, 2021 (view filing)Aug 121 dayGuenthner RobertChief Legal OfficerSSaleCommon Stock, $0.001 par value−5.90K$50.73−$299.4K−1.2%494.2K after4 lots
Aug 11, 2021 (view filing)Aug 101 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−50.0K$53.08−$2.65M−1.8%2.65M after4 lots
Aug 6, 2021 (view filing)Aug 51 dayPrice Geoffrey MChief Operating OfficerSSaleCommon Stock, $0.001 par value−7.89K$65.12−$514.0K−0.3%2.70M after